#sleepheath #drugdevelopment #Eisai #narcolepsy #narcolepsydrug #E2086 #Novelorexinreceptoragonist #wakefulness #WorldSleep2025 #daytimewakefulness #narcolepsytype1 #clinicaltrialparticipants #MaintenanceofWakefulnessTest #MWT #KarolinskaSleepinessScale #KSS #sleeplatency
zurl.co/KAgBH
zurl.co/KAgBH
Eisai unveils promising phase 1b data for narcolepsy drug E2086 - PharmaTimes
Novel orexin receptor agonist shows potential to improve wakefulness
pharmatimes.com
September 11, 2025 at 8:33 AM